ArticleTranslational cancer research2025
Knockdown of MIR205HG prevents cell proliferation, migration and invasion through autophagy and ferroptosis pathways in lung adenocarcinoma.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The MIR205 host gene (MIR205HG) has been reported to play important roles in various cancers. However, its role in the occurrence and development of lung cancer remains to be clarified. This study aimed to analyze the function and molecular mechanisms of MIR205HG in lung adenocarcinoma (LUAD). Methods: The RNA sequencing (RNA-Seq) dataset was used to examine MIR205HG expression. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze the expression of MIR205HG in LUAD tissues and adjacent tissues. It was also employed to examine the expression of MIR205HG in LUAD cell lines. Water-Soluble Tetrazolium 1 (WST-1), colony formation assay, transwell assay and flow cytometry assay were used to explore the function of MIR205HG in lung cancer cells. Immunofluorescence assay was applied to examine the formation of autophagosomes. Western blot assay was used to analyze the expression of autophagy-related proteins and ferroptosis-related protein. Results: MIR205HG was highly expressed in LUAD tissues compared to adjacent tissues. Knockdown of MIR205HG expression prevented cell growth, migration, and invasion, and promoted apoptosis in LUAD cells. Western blot results showed that autophagy-related proteins, AMPK, BECLIN-1, and LC3B, were increased, while p62, mTOR and the ferroptosis-related protein GPX4 were decreased after MIR205HG knockdown. Conclusions: Knockdown of MIR205HG inhibits the development of LUAD through autophagy and ferroptosis pathways, suggesting that MIR205HG may be a potential target in the diagnosis and therapeutic treatment of LUAD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.